| Generic Name |
Brand Name |
Breast Cancer Stage |
Breast Cancer Subtype |
Type of Therapy |
Where is This Drug in the Approval Process? |
| Atezolizumab |
Tecentriq |
Stage IV (metastatic) |
Triple negative |
Targeted therapy |
Approved for sale in Canada (Health Canada) |
| Capecitabine |
Xeloda, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Carboplatin |
Paraplatin |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Cisplatin |
Platinol, and various generic versions |
Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Cyclophosphamide |
Cytoxan, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Docetaxel |
Taxotere, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Doxorubicin |
Adriamycin, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Epirubicin |
Pharmorubicin, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Eribulin |
Halaven |
Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Public funding review process (CDA/INESSS), Provincial/territorial price negotiation (pCPA), Listed on a provincial/territorial drug formulary |
| Fluorouracil Injection |
Fluorouracil Injection, and various generic versions |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Gemcitabine |
Gemzar, and various generic versions |
Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Methotrexate |
Metoject |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Mitoxantrone |
Novantrone |
Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| nab-Paclitaxel |
Abraxane, and various generic versions |
Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Public funding review process (CDA/INESSS), Listed on a provincial/territorial drug formulary |
| Olaparib |
Lynparza |
Stage IV (metastatic) |
HR positive, Triple negative |
Targeted therapy |
Approved for sale in Canada (Health Canada) |
| Olaparib |
Lynparza |
Stage I, Stage II, Stage III |
HR positive, Triple negative |
Targeted therapy |
Approved for sale in Canada (Health Canada), Public funding review process (CDA/INESSS), Provincial/territorial price negotiation (pCPA), Listed on a provincial/territorial drug formulary |
| Paclitaxel |
Taxol |
Stage I, Stage II, Stage III, Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Pegylated Liposomal Doxorubicin |
Caelyx, and various generic versions |
Stage IV (metastatic) |
HR positive, HER2 positive, Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |
| Pembrolizumab |
Keytruda |
Stage IV (metastatic) |
Triple negative |
Immunotherapy |
Approved for sale in Canada (Health Canada), Public funding review process (CDA/INESSS), Provincial/territorial price negotiation (pCPA), Listed on a provincial/territorial drug formulary |
| Pembrolizumab |
Keytruda |
Stage I, Stage II, Stage III |
Triple negative |
Immunotherapy |
Approved for sale in Canada (Health Canada), Public funding review process (CDA/INESSS), Provincial/territorial price negotiation (pCPA), Listed on a provincial/territorial drug formulary |
| Sacituzumab govitecan |
Trodelvy |
Stage IV (metastatic) |
Triple negative |
Targeted therapy |
Approved for sale in Canada (Health Canada), Public funding review process (CDA/INESSS), Provincial/territorial price negotiation (pCPA), Listed on a provincial/territorial drug formulary |
| Vinorelbine |
Navelbine, and various generic versions |
Stage IV (metastatic) |
Triple negative |
Chemotherapy |
Approved for sale in Canada (Health Canada), Listed on a provincial/territorial drug formulary |